TrialRetrovirology2018

Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.

Alinda G Vos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.